Improvement in bedtime plasma glucose level serves as a predictor of long-term blood glucose control in patients with Type 2 diabetes: A study with monotherapy of 50/50 premixed insulin analogue three times daily injection

Masami Tanaka, Hitoshi Ishii

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aim: To examine which timing of blood glucose level is more important to achieve adequate blood glucose control with insulin lispro mixture-50 (Mix 50) three times daily (TID) monotherapy. Methods: The study enrolled 35 Type 2 diabetic patients. Blood glucose levels before each meal and at bedtime were measured 2 weeks after the start of the study and were analyzed in relation to improvement in hemoglobin A1c (HbA1c) at 6-8 weeks and 6 months. Results: HbA1c improved significantly (10.1±1.6 % at baseline, 7.8±1.1 % at 6-8 weeks and 6.8±1.1 % at 6 months). Only the blood glucose level measured at bedtime correlated with improvement in HbA1c at 6-8 weeks. For the insulin-naïve patients, only bedtime plasma glucose level also had a significant correlation with improvement in HbA1c at 6 months. Conclusions: Bedtime plasma glucose level can serve as a predictor of the outcome of long-term blood glucose control during Mix 50 TID monotherapy and that bedtime plasma glucose level needs to be reduced sufficiently to achieve adequate blood glucose control.

Original languageEnglish
Pages (from-to)83-89
Number of pages7
JournalJournal of Diabetes and its Complications
Volume25
Issue number2
DOIs
Publication statusPublished - 2011 Mar 1
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Blood Glucose
Insulin
Glucose
Injections
Hemoglobins
Insulin Lispro
Biphasic Insulins
Meals

Keywords

  • 50/50 premixed rapid-acting insulin analogue
  • Bedtime plasma glucose
  • Blood glucose control
  • Hypoglycemia
  • Insulin therapy

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

@article{2f23b15cccc046eeb5fc7a5938437c48,
title = "Improvement in bedtime plasma glucose level serves as a predictor of long-term blood glucose control in patients with Type 2 diabetes: A study with monotherapy of 50/50 premixed insulin analogue three times daily injection",
abstract = "Aim: To examine which timing of blood glucose level is more important to achieve adequate blood glucose control with insulin lispro mixture-50 (Mix 50) three times daily (TID) monotherapy. Methods: The study enrolled 35 Type 2 diabetic patients. Blood glucose levels before each meal and at bedtime were measured 2 weeks after the start of the study and were analyzed in relation to improvement in hemoglobin A1c (HbA1c) at 6-8 weeks and 6 months. Results: HbA1c improved significantly (10.1±1.6 {\%} at baseline, 7.8±1.1 {\%} at 6-8 weeks and 6.8±1.1 {\%} at 6 months). Only the blood glucose level measured at bedtime correlated with improvement in HbA1c at 6-8 weeks. For the insulin-na{\"i}ve patients, only bedtime plasma glucose level also had a significant correlation with improvement in HbA1c at 6 months. Conclusions: Bedtime plasma glucose level can serve as a predictor of the outcome of long-term blood glucose control during Mix 50 TID monotherapy and that bedtime plasma glucose level needs to be reduced sufficiently to achieve adequate blood glucose control.",
keywords = "50/50 premixed rapid-acting insulin analogue, Bedtime plasma glucose, Blood glucose control, Hypoglycemia, Insulin therapy",
author = "Masami Tanaka and Hitoshi Ishii",
year = "2011",
month = "3",
day = "1",
doi = "10.1016/j.jdiacomp.2010.05.001",
language = "English",
volume = "25",
pages = "83--89",
journal = "Journal of Diabetes and its Complications",
issn = "1056-8727",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Improvement in bedtime plasma glucose level serves as a predictor of long-term blood glucose control in patients with Type 2 diabetes

T2 - A study with monotherapy of 50/50 premixed insulin analogue three times daily injection

AU - Tanaka, Masami

AU - Ishii, Hitoshi

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Aim: To examine which timing of blood glucose level is more important to achieve adequate blood glucose control with insulin lispro mixture-50 (Mix 50) three times daily (TID) monotherapy. Methods: The study enrolled 35 Type 2 diabetic patients. Blood glucose levels before each meal and at bedtime were measured 2 weeks after the start of the study and were analyzed in relation to improvement in hemoglobin A1c (HbA1c) at 6-8 weeks and 6 months. Results: HbA1c improved significantly (10.1±1.6 % at baseline, 7.8±1.1 % at 6-8 weeks and 6.8±1.1 % at 6 months). Only the blood glucose level measured at bedtime correlated with improvement in HbA1c at 6-8 weeks. For the insulin-naïve patients, only bedtime plasma glucose level also had a significant correlation with improvement in HbA1c at 6 months. Conclusions: Bedtime plasma glucose level can serve as a predictor of the outcome of long-term blood glucose control during Mix 50 TID monotherapy and that bedtime plasma glucose level needs to be reduced sufficiently to achieve adequate blood glucose control.

AB - Aim: To examine which timing of blood glucose level is more important to achieve adequate blood glucose control with insulin lispro mixture-50 (Mix 50) three times daily (TID) monotherapy. Methods: The study enrolled 35 Type 2 diabetic patients. Blood glucose levels before each meal and at bedtime were measured 2 weeks after the start of the study and were analyzed in relation to improvement in hemoglobin A1c (HbA1c) at 6-8 weeks and 6 months. Results: HbA1c improved significantly (10.1±1.6 % at baseline, 7.8±1.1 % at 6-8 weeks and 6.8±1.1 % at 6 months). Only the blood glucose level measured at bedtime correlated with improvement in HbA1c at 6-8 weeks. For the insulin-naïve patients, only bedtime plasma glucose level also had a significant correlation with improvement in HbA1c at 6 months. Conclusions: Bedtime plasma glucose level can serve as a predictor of the outcome of long-term blood glucose control during Mix 50 TID monotherapy and that bedtime plasma glucose level needs to be reduced sufficiently to achieve adequate blood glucose control.

KW - 50/50 premixed rapid-acting insulin analogue

KW - Bedtime plasma glucose

KW - Blood glucose control

KW - Hypoglycemia

KW - Insulin therapy

UR - http://www.scopus.com/inward/record.url?scp=79952316761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952316761&partnerID=8YFLogxK

U2 - 10.1016/j.jdiacomp.2010.05.001

DO - 10.1016/j.jdiacomp.2010.05.001

M3 - Article

C2 - 20573523

AN - SCOPUS:79952316761

VL - 25

SP - 83

EP - 89

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 2

ER -